GGrantIndex
← Leaderboards

Chun Geun Lee

Yale University

$5,468,680
Attributed
$5,468,680
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $763K · FY200724
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,468,680 · 3

By mechanism

R01$5,468,680 · 3

Top collaborators

No co-investigators on record.

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Evaluation

Research focus

EvaluationInflammationMyofibroblastPathogenesisResponseLungProteinsFibrosisPulmonary FibrosisTissuesSignal TransductionChronic Obstructive Airway DiseaseTransforming Growth FactorsApoptosisTransgenic OrganismsGenerationsEpithelial CellsAnimal ModelProductionTransforming Growth Factor BetaLifeIn VivoInterstitial Lung DiseasesLung Diseases

Grant awards (14)

Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2024 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2023 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$398,750
R01 · FY2022 · HL · contact PI
Chitinase1 Regulation of Pulmonary Fibrosis and Therapeutic Targeting$397,500
R01 · FY2021 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$355,941
R01 · FY2017 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$358,644
R01 · FY2016 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$360,409
R01 · FY2015 · HL · contact PI
Chitinase1 as a Biomarker and Therapeutic Target in Scleroderma Lung Disease$383,908
R01 · FY2014 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2011 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2010 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,750
R01 · FY2009 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$349,258
R01 · FY2009 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$413,020
R01 · FY2008 · HL · contact PI
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis$412,500
R01 · FY2007 · HL · contact PI